How Many Mg of Melatonin Should I Take? Research-Backed Dosage 2026

We earn a commission if you make a purchase through our links, at no extra cost to you. Not medical advice — consult your doctor before starting or changing any supplement.

For most adults, the right melatonin dose is 0.3–1 mg taken 30–60 minutes before target bedtime — not the 5 or 10 mg tablets stocked on pharmacy shelves. Higher doses do not work better for sleep; in controlled trials, a 0.3 mg dose has repeatedly matched or outperformed 3 mg and 5 mg for sleep-onset latency, with fewer next-day side effects. The rest of this guide translates that finding into concrete dosing by age, use case, timing, and drug interactions.

What Peer-Reviewed Research Shows

Melatonin is one of the most-studied OTC sleep aids in the literature. The consistent finding across four decades: it is a circadian signal, not a sedative, and typical retail doses are 5–30× higher than what controlled studies support.

• Wurtman et al. (MIT, 2001): In older adults, 0.3 mg restored sleep efficiency to young-adult values. A 3 mg dose produced supra-physiological plasma levels associated with hypothermia and next-day grogginess.
• Brzezinski et al. meta-analysis (Sleep Medicine Reviews, 2005): Across 17 RCTs, melatonin significantly reduced sleep-onset latency but effect size was largely independent of dose across 0.3–5 mg — consistent with receptor saturation at very low doses.
• Auld et al. systematic review (Sleep Medicine Reviews, 2017): Reliable benefit for delayed sleep phase disorder and jet lag; weaker for primary insomnia. The review flagged US OTC doses as often far exceeding therapeutic need.
• AASM clinical practice guideline (2017, updated 2022): Recommended as adjunctive therapy for jet lag and circadian rhythm disorders, with a preference for 0.3–0.5 mg at the correct phase. Not recommended as first-line for chronic insomnia — CBT-I is.
• Erland & Saxena (Journal of Clinical Sleep Medicine, 2017): 31 US products tested: actual content ranged from 83% below to 478% above label, with 26% containing serotonin impurity. Brand quality and USP verification matter.
• Pediatric systematic review (Pediatrics, 2019): 0.5–3 mg improved sleep onset in children with ADHD and autism-spectrum sleep disorders, under pediatrician oversight.
• Pharmacokinetics: Peak plasma at 40–60 min; half-life 40–60 min immediate-release, 3–4 h extended-release. 0.3 mg approximates the natural nocturnal peak; 5 mg pushes plasma 10–20× above physiological.

The takeaway. MT1 and MT2 receptors are largely saturated at physiological levels. More melatonin after saturation doesn't create a stronger signal — just a longer one, beyond the window your circadian system can use. Low dose, right timing, right form. That is the whole game, and it is the reason the European prescription standard for adults 55+ is a 2 mg extended-release tablet rather than the 5 or 10 mg amounts sold over-the-counter in the US.

Standard Dosage Chart by Use Case

Dose should match the sleep problem, not a one-size bedtime number. The chart below reflects the doses used in controlled trials — not what's on the pharmacy label. Start at the low end and titrate only if sleep onset hasn't improved after 5–7 nights at the same timing.

US retail defaults of 3, 5, and 10 mg exist largely because those amounts fit existing tablet presses, not because trials show them to be more effective. In Europe, the prescription 2 mg extended-release formulation (Circadin) is the closest to a pharmaceutical melatonin standard.

Why Lower Doses Often Work Better

Three mechanisms explain why 0.3 mg can beat 5 mg for sleep onset:

• Receptor saturation. MT1 and MT2 are high-affinity receptors; a 0.3 mg oral dose largely occupies them. More ligand doesn't create a stronger signal — just a longer one, beyond the circadian window.
• Morning grogginess (the "melatonin hangover"). 5 or 10 mg keeps plasma levels elevated into morning hours when cortisol should dominate. That collision produces the groggy, "hungover" feeling usually blamed on the supplement itself.
• Receptor desensitization. Chronic supra-physiological dosing down-regulates MT1/MT2 over weeks, which is why 5 mg nightly often "stops working." 0.3–0.5 mg avoids the effect in published data.

If you've been taking 5 or 10 mg, dropping to 0.5 mg (split a 1 mg tablet or use a liquid drop) for a week is the single most useful experiment you can run.

Dosage by Age Group

Endogenous melatonin peaks in mid-childhood, declines through adulthood, and by age 70 is roughly a third of young-adult levels. That trajectory is the backbone of age-adjusted dosing.

• Children (3–12): Pediatrician guidance only. 0.5–1 mg typical, up to 3 mg under supervision for ADHD or autism-spectrum sleep issues. Avoid gummies — the AAP has specifically warned about accidental overdose.
• Adolescents (13–18): DSPS is common, so the strategy is timing (4–6 h before desired bedtime) more than dose. 0.3–1 mg is almost always sufficient.
• Adults (19–54): 0.3–1 mg is the evidence-based range. Higher doses are commonly sold but not better supported, and they produce more next-day side effects.
• Older adults (55+): Endogenous production has declined; supplementation is more impactful. 1–2 mg extended-release (Circadin-style) is best studied for sleep maintenance. Immediate-release 0.5–1 mg for sleep onset.
• Seniors (70+): Start at 0.3 mg. Drug interactions and reduced hepatic clearance make low-dose initiation more important, not less.

Body weight is a secondary consideration, not a driver. Melatonin isn't weight-dosed the way many medications are — the relevant pharmacology is receptor occupancy, not systemic concentration. A 220-lb adult and a 130-lb adult generally do well on the same 0.5 mg dose if timing and formulation match the sleep problem.

Timing: The Dose Before the Dose

When you take melatonin matters as much as how much. It is a phase-shifter; taking it "when you want to sleep now" is the most common user error.

• Standard sleep onset: 30–60 min before target bedtime. Later than 30 risks missing the drowsiness window.
• Delayed sleep phase (shifting earlier): 4–6 h before your current natural sleep time. If you fall asleep at 2 a.m. and want 11 p.m., dose at 5–7 p.m. — counterintuitive, but this is the clinic protocol.
• Eastward jet lag: At destination bedtime for 3–5 nights. Pre-shifting 2–3 days before departure reduces arrival symptoms.
• Westward jet lag: Usually not needed — westward travel is biologically easier.
• Shift work: 30–60 min before target sleep window, room fully dark. An hour off makes the dose ineffective.

If melatonin "didn't work" for you, check timing before you adjust dose. A 0.3 mg tablet at the right phase reliably outperforms a 5 mg gummy at the wrong one.

Signs You're Taking Too Much

If you notice two or more of the following for a week, halve your dose and re-assess after 5 nights:

• Vivid or disturbing dreams. Supra-physiological melatonin alters REM architecture.
• Morning fog past 9 a.m. Classic "melatonin hangover" from plasma levels still elevated into the day.
• Morning headache. Usually a dose-too-high issue that resolves at 0.5 mg.
• Daytime drowsiness. If you're fighting sleep at 2 p.m., the dose or timing (or both) is off.
• Rebound insomnia on stop-days. Baseline drive blunted by chronic dosing — taper.
• Lowered mood or irritability. More common at 5–10 mg than at 0.3–1 mg.
• "Stopped working." Classic receptor desensitization. Drop to 0.3 mg for 2 weeks or take a 1–2 week break.

Dose Adjustment for Specific Conditions

The right dose is contextual. The conditions below meaningfully change amount or timing — always in consultation with your physician if you're on other medications.

• Travel across time zones. 0.5–1 mg at destination bedtime for 3–5 nights eastward. Pre-shift 1–3 days before departure if you can. Skip for westward travel under 4 zones.
• Chronic primary insomnia. Not first-line. AASM recommends CBT-I; melatonin is supplementary at 0.5–1 mg.
• Anxiety-related sleep onset. Same melatonin dose (0.3–1 mg); add L-theanine (100–200 mg) or magnesium glycinate (200–400 mg) — they target the anxiety component more directly.
• ADHD sleep onset (adult): 0.5–3 mg range in trials, 30–60 min before bed. Stimulant timing matters more than melatonin dose — morning-only dosing often solves the problem.
• Perimenopausal sleep disruption. Extended-release 1–2 mg is better studied; addresses 3 a.m. wake-ups that immediate-release can't.
• Dementia-related sundowning: specialist-supervised only. 1–3 mg studied; effects mixed.

Drug Interactions

Melatonin isn't inert. These drug classes warrant a pharmacist or physician conversation before regular use:

• Anticoagulants/antiplatelets (warfarin, apixaban, clopidogrel): Mild antiplatelet effects; case reports of increased bleeding risk. Low dose (0.3–0.5 mg), physician sign-off.
• Diabetes medications: Modestly impairs glucose tolerance at supra-physiological doses. Monitor morning glucose, keep dose low.
• Immunosuppressants (cyclosporine, tacrolimus, biologics): Avoid without specialist approval.
• Hormonal birth control: OCPs inhibit CYP1A2 and amplify supplemental melatonin. 0.3–0.5 mg is usually plenty.
• Benzodiazepines and Z-drugs: Additive sedation. Use the lowest effective melatonin dose.
• Antidepressants: Fluvoxamine inhibits CYP1A2 and can raise melatonin exposure up to 20×. Start at 0.3 mg.
• Antihypertensives (beta-blockers especially): Beta-blockers suppress endogenous melatonin, so supplementation is more impactful. Monitor BP.
• Alcohol: Degrades sleep architecture and dominates any melatonin benefit. Within 3 h of bed, skip the dose.

Extended-Release vs Immediate-Release

Two products, two problems. Choosing the wrong formulation is a common reason users conclude "melatonin doesn't work for me."

• Immediate-release (tablets, sublingual, drops): Onset 20–60 min; half-life 40–60 min. Best for sleep onset. Dose 0.3–1 mg. Sublingual onsets faster (15–20 min) by bypassing first-pass metabolism.
• Extended-release (Circadin-style): Gradual release over 3–4 h. Best for sleep maintenance (3 a.m. wake-ups). Dose 1–2 mg.
• Avoid: ER for sleep-onset — peak hits too late and the tail causes morning grogginess.
• Avoid: Immediate-release for 3 a.m. wake-ups — plasma is back to baseline by then.
• Combined: Some clinicians pair 0.5 mg immediate-release with 1 mg ER for both issues. Doctor-supervised only.

What Physicians and Pharmacists Recommend

We reviewed guidance from AASM, APhA, USP, and NSF. The consensus is aligned:

• AASM. Recommended for jet lag and circadian rhythm disorders; not first-line for chronic insomnia (CBT-I is). Start 0.3–0.5 mg.
• APhA. Low dose (0.5–1 mg) for occasional short-term use. Pharmacists flag adult doses >3 mg and any pediatric dose >1 mg without pediatrician involvement.
• USP. As a supplement, melatonin isn't held to pharmaceutical potency requirements. USP Verified confirms identity, strength, and purity — the single best label to look for.
• NSF. NSF Certified for Sport / Contents Tested is third-party verification. Thorne, NOW Foods, and Natrol have USP or NSF-audited lines.
• AAP (pediatrics). Reasonable in specific clinical contexts (ADHD, ASD, chronic sleep-onset insomnia) under pediatrician guidance only, never as a substitute for sleep hygiene.

Practical takeaway: look for USP Verified or NSF Certified, and start at 0.5 mg unless a clinician says otherwise.

Alternatives When Melatonin Isn't Right

For many users melatonin isn't the right tool — either the problem is downstream of circadian signaling (anxiety, hyperarousal, sleep apnea) or they want to avoid hormone supplementation:

• NooCube Sleep Upgrade — melatonin-free stack (lemon balm 600 mg, magnesium, lavender, calcium, vitamin D3). No tolerance or dependency profile. See our NooCube Sleep review.
• Magnesium glycinate or citrate (200–400 mg at bedtime). Useful when insomnia has an anxiety or muscle-tension component. See magnesium for sleep.
• L-theanine (100–200 mg). Blunts evening hyperarousal without sedation. See L-theanine sleep guide.
• CBT-I. AASM first-line for chronic insomnia. Somryst (FDA-cleared), Sleepio, provider-led programs. See CBT-I guide.
• Sleep hygiene basics. Consistent wake time, 65–68°F bedroom, blackout curtains, no screens 60 min before bed. See insomnia tips and insomnia remedies.
• Sleep study. If low-dose melatonin, timing, and environment are fixed and you still can't sleep, undiagnosed apnea is the next thing to rule out.

FAQ

Is 10 mg of melatonin too much?
Yes for most adults — 10–30× the therapeutic dose in controlled trials. Higher dose doesn't mean better sleep, and 10 mg nightly is associated with morning grogginess and receptor desensitization. Try 0.5 mg for a week before concluding melatonin "doesn't work anymore."

What's the right dose for a child?
Pediatrician-supervised only. 0.5–1 mg typical, up to 3 mg under supervision for ADHD- or autism-related issues. Use tablets or liquid drops, not gummies — the AAP has flagged gummy overdose risk.

Is it OK to take melatonin every night long-term?
Low-dose (0.3–0.5 mg) nightly use appears well-tolerated in available research, with limited data past 2 years. High-dose chronic use is associated with receptor desensitization. If you need it nightly for more than a few months, talk to your physician about CBT-I.

Can I take melatonin with alcohol?
Not recommended. Alcohol fragments sleep architecture and will dominate any melatonin benefit. More than one drink within 3 h of bed — skip the dose that night.

Empty stomach or with food?
Empty stomach. Food (especially carbohydrate-heavy meals) delays absorption and cuts peak plasma by 30–50%. Finish dinner at least 2 h before your dose.

When should I take extended-release melatonin?
30 minutes before bedtime, not 60. ER releases over 3–4 h, so an earlier dose risks peaking too soon and leaving a groggy tail in the morning.

Gummies vs tablets: does it matter?
Yes. Gummies are the most commonly overdosed form and most frequently mislabeled (Erland & Saxena 2017 showed the highest variance in gummies). For precise 0.5 mg dosing, a split 1 mg tablet or a liquid drop beats any gummy on the market.

Does melatonin interact with antidepressants?
It can. Fluvoxamine inhibits CYP1A2 and can raise melatonin exposure 10–20× — start at 0.3 mg. Other SSRIs and SNRIs have milder interactions; a quick pharmacist check is worth it.

Sublingual vs swallowed: is there a real difference?
Yes for speed. Sublingual onsets in 15–20 min vs 30–60 for swallowed tablets because it bypasses first-pass metabolism. For strict-routine sleep onset, sublingual is cleaner; for general bedtime dosing, tablets are fine.

Related reading: NooCube Sleep Review | Does Melatonin Expire? | Is Melatonin Safe Long Term? | Melatonin for Sleep | Magnesium for Sleep | L-Theanine for Sleep | CBT-I for Sleep | Insomnia Tips | Insomnia Remedies